New 3D Bioprinting Platform Combines Coaxial Nozzle and Rotating Bioreactor for Vascular Tissue Engineering

One of the greatest challenges in 3D bioprinting is creating functional vascular structures that can supply oxygen and nutrients to engineered tissues. Without robust vascularization, most bioprinted tissues fail to survive and integrate after implantation. Addressing this challenge, researchers have developed a novel 3D bioprinting platform that integrates an extrusion-based coaxial nozzle with a modified rotating bioreactor, paving the way for more effective vascular tissue engineering.

Printing with Precision

The coaxial nozzle enables the fabrication of hollow, tubular structures that mimic natural blood vessels. By extruding bioinks and crosslinking agents simultaneously, the platform ensures precise lumen diameters, wall thickness, and improved structural integrity. This approach not only accelerates fabrication but also enhances angiogenesis—the natural process of blood vessel formation—during culture.

Dynamic Bioreactor Environment

Unlike static systems, the modified rotating bioreactor provides a dynamic culture environment that supports continuous nutrient delivery, oxygen regulation, and waste removal. Using programmable logic controllers (PLC) and LabVIEW simulations, the system maintains optimal parameters such as pH (7.2–7.4), oxygen (~6%), and CO₂ (~10%), all critical for cell viability and vascular maturation.

Computational and Experimental Validation

The platform was tested with computational fluid dynamics (CFD) and uncertainty analysis, confirming stable shear stress distribution and minimal pressure fluctuations. This level of control ensures consistent cell growth, reducing risks of rupture or mechanical instability often seen in conventional vascular bioprinting approaches.

Implications for Regenerative Medicine

By integrating engineering precision with biological processes, this new platform could transform vascularized organ fabrication, transplantable tissues, and advanced drug testing models. With global demand for organ transplants far exceeding supply, such breakthroughs hold the promise of on-demand, patient-specific bioprinted tissues.

This hybrid design of coaxial nozzle printing and rotating bioreactor culture marks a critical step toward achieving clinically viable vascularized tissues—bringing the future of regenerative medicine closer to reality.

Reference

Deshmukh, K., Kumar, J., Singh, N. K., & Bit, A. (2025). A Novel 3D Bioprinting Platform Integrating Coaxial Nozzle and Modified Rotating Bioreactor for Angiogenesis-Guided Vascular Tissue Engineering. Journal of Materials Engineering and Performance, 1-16. https://doi.org/10.1007/s11665-025-11849-4